September 21, 2016
Otsuka Pharmaceutical Co. on Monday filed a complaint in New Jersey federal court alleging two India-based pharmaceutical companies and an American subsidiary are infringing two of its patents by seeking to manufacture and sell a generic version of schizophrenia drug Abilify.